Heart failure and diabetes: a two-way street for brain health
A new study investigates the complex interplay between heart failure events and the onset of new diabetes in patients with heart failure and mildly reduced or preserved ejection fraction, and the potential role of the drug finerenone. While the primary focus is cardiometabolic, this research underscores the critical link between systemic vascular health and neurological outcomes. The findings highlight how cardiovascular events can precipitate metabolic dysfunction, creating a cascade of risk factors—such as chronic inflammation and impaired cerebral blood flow—that are central to the pathogenesis of cognitive impairment, vascular dementia, and stroke.
Why it might matter to you: For a neurologist, this research reinforces the importance of a holistic patient assessment that integrates cardiovascular and metabolic risk profiles. Understanding this interplay is crucial for managing patients with vascular cognitive impairment or those at high risk for stroke, as it points to potential upstream therapeutic targets. The study’s methodology in tracking event-driven disease progression offers a model for investigating how systemic health crises can accelerate neurodegenerative or neurovascular pathology.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.